Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Diabetes. Jul 15, 2022; 13(7): 521-531
Published online Jul 15, 2022. doi: 10.4239/wjd.v13.i7.521
Table 3 Descriptive statistics of main variables analyzed in individuals of group 3 (bisphenol F)
BPF quartile
Q1
Q2
Q3
Q4
n912912922912
Age41.22 (40.04-42.42)44.81 (43.59-46.06)c45.22 (44.02-46.46)d43.69 (42.5-44.92)a
Gender, % of men58.244.543.743
BMI, kg/m229.04 (28.61-29.48)28.01 (27.6-28.43)b28.04 (27.63-28.45)b28.59 (28.16-29.02)
Diabetes mellitus, %17.119.716.416.9
Fasting glucose, mg/dL108.3 (105.9-110.7)106.2 (103.9-108.6)104.7 (102.6-106.9)105.6 (5.63-5.75)
HbA1c, %5.7 (5.64-5.75)5.74 (5.68-5.81)5.69 (5.63-5.75)5.69 (5.63-5.75)
Smoker, %38.640.946.449.3
Cotinine, serum, ng/mL0.18 (0.14-0.23)0.19 (0.15-0.25)0.29 (0.22-0.38)0.43 (0.33-0.57)c,e,f
Hypertension, %39.74243.344.4
Systolic blood pressure, mmHg121.9 (120.9-123.1)122.9 (121.8-124.1)123 (121.8-124.1)122.3 (121.1-123.5)
Diastolic blood pressure, mmHg68.73 (67.93-69.53)68.53 (67.76-69.31)68.79 (67.94-69.64)68.95 (68.1-69.82)
Dyslipidemia, %37.64143.440.2
Total cholesterol, mg/dL185.3 (182.2-187.9)186.9 (184.1-189.8)186.7 (184.1-189.4)185-9 (183.3-188.6)
BPS, µg/g creatinine0.48 (0.44-0.51)0.5 (0.46-0.54)0.55 (0.51-0.59)0.54 (0.50-0.58)